Cargando…
Docetaxel in very elderly men with metastatic castration-resistant prostate cancer
PURPOSE: To evaluate the use of docetaxel in very elderly men with metastatic castration-resistant prostate cancer (mCRPC) treated in routine clinical care. METHODS: A retrospective case series of men with mCRPC aged ≥80 years and treated with docetaxel between July 2006 and June 2012 at three commu...
Autores principales: | Wong, Hui-Li, Lok, Sheau Wen, Wong, Shirley, Parente, Phillip, Rosenthal, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494632/ https://www.ncbi.nlm.nih.gov/pubmed/26157766 http://dx.doi.org/10.1016/j.prnil.2015.03.003 |
Ejemplares similares
-
The Influence of Prednisone on the Efficacy of Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer
por: Teply, Benjamin A., et al.
Publicado: (2015) -
Efficacy and Safety of Docetaxel in Elderly Patients With Metastatic
Castration-Resistant Prostate Cancer
por: Maia, Manuel Caitano, et al.
Publicado: (2017) -
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel
por: Halabi, Susan, et al.
Publicado: (2020) -
Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions
por: Caffo, Orazio, et al.
Publicado: (2016) -
Activity of enzalutamide in men with metastatic castration resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel
por: Cheng, Heather H., et al.
Publicado: (2015)